Joeo Marcelo Eboli
Director and Partner
Porto Alegre, Rio Grande do Sul
Joeo Marcelo Eboli, Director and Partner is an active investor based in Porto Alegre, Rio Grande do Sul. This profile covers what Joeo Marcelo Eboli backs, at which stage, and how founders can reach out in 2026.
- Investor type
- Angel
- Stages
- Pre SeedSeed
- Location
- Porto Alegre, Rio Grande do Sul
- Typical check
- $150K
How to reach Joeo Marcelo Eboli
Angels and operators like Joeo Marcelo Eboli reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Connect with Joeo Marcelo Eboli
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise.
Frequently Asked Questions
Who is Joeo Marcelo Eboli?
Joeo Marcelo Eboli is an active investor, Director and Partner. Round Funded tracks their focus and activity alongside thousands of investors.
What stage does Joeo Marcelo Eboli invest at?
Joeo Marcelo Eboli typically invests at Pre Seed and Seed. Lead with traction that fits the stage when you reach out.
What is Joeo Marcelo Eboli's typical check size?
Joeo Marcelo Eboli typically writes checks around $150K. Use it as a signal for whether your raise fits their stage.
How do I contact Joeo Marcelo Eboli?
Unlock Joeo Marcelo Eboli's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.